BMRN

BUSINESS

Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)  is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. Gena Wang of…

Read More »
Back to top button